Market Overview

UPDATE: Jefferies Downgrades HealthSouth Corporation to Hold on Regulatory Headwinds

Share:
Related HLS
Benzinga's M&A Chatter for Monday November 24, 2014
Top 4 NYSE Stocks In The Specialized Health Services Industry With The Highest Profit Margin
Zimmer (ZMH) Likely to Miss Estimates this Earnings Season - Analyst Blog (Zacks)

Jefferies lowered its HealthSouth Corporation (NYSE: HLS) rating from Buy to Hold and reduced its price target from $25 to $23.

Jefferies noted, "HLS's strong Q2 performance and raised guidance was impressive, but we recommend taking advantage of stock strength to lighten long positions, fearing that IRF reimbursement could get greater scrutiny later this year when legislators look for funding offsets to another doc fix and deficit reduction."

HealthSouth Corporation closed at $22.93 on Thursday.

Latest Ratings for HLS

DateFirmActionFromTo
Jan 2015BarclaysMaintainsEqual-weight
Jul 2014BarclaysMaintainsEqual-weight
Jul 2014Mizuho SecuritiesMaintainsBuy

View More Analyst Ratings for HLS
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Downgrades Intraday Update Analyst Ratings

 

Related Articles (HLS)

Around the Web, We're Loving...

Get Benzinga's Newsletters